80
Participants
Start Date
December 14, 2023
Primary Completion Date
November 24, 2025
Study Completion Date
November 24, 2028
Daily-adaptive Stereotactic Body Radiation Therapy
Daily-adaptive radiation therapy to two dose levels - one to the area of radiologic recurrent nodal disease, and a lower, prophylactic dose to the standard post-prostatectomy and larger pelvic node fields
Daily-adaptive Stereotactic Body Radiation Therapy
Daily-adaptive radiation therapy to two areas - a high dose to the area of radiologic recurrence, and a lower, prophylactic dose to the standard post-prostatectomy fields
RECRUITING
Wilmot Cancer Institute - Dept of Radiation Oncology, Rochester
Collaborators (1)
Varian Medical Systems
INDUSTRY
University of Rochester
OTHER